Skip to main content

Advertisement

SpringerLink
Log in

Effects of nutritional therapy on gastrointestinal microbial digestion and barrier defense markers in elderly patients with diabetes

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Objective

We sought to investigate the effects of gastrointestinal nutrition therapy on gastrointestinal microbial digestion and barrier defense markers in elderly patients with diabetes.

Methods

A total of 120 elderly patients with type 2 diabetes were enrolled at our hospital between January 2020 and December 2022. The participants in this study were randomly allocated into either the nutritional group (n = 60) who underwent gastrointestinal nutrition therapy or the control group (n = 60) who underwent conventional T2DM diet management for a period of 12 weeks. Clinical data, as well as small intestinal permeability measured by the lactulose-mannitol urine test, plasma circulating IL-6 and zonulin levels measured by ELISA, and expressions of ZO-1 and Claudin-3 in blood analyzed through Western blotting were collected.

Results

The nutrition group demonstrated a higher proportion of patients achieving HbA1c < 7% compared to the control group (P < 0.05). Moreover, the nutrition group exhibited a greater reduction in fasting and postprandial blood glucose levels compared to the control group (P < 0.05). The concentrations of formate-tetrahydrofolate ligase and acetic CoA transferase were significantly increased in the nutrition group compared to the control group (P < 0.05). Fecal analysis revealed higher levels of acetic acid and butyric acid in the nutrition group compared to the control group (P < 0.05). The ratio of lactulose to mannitol was higher in the nutrition group compared to the control group (P < 0.05). Furthermore, the nutrition group showed lower levels of IL-6 and zonulin compared to the control group (P < 0.05).

Conclusion

Personalized gastrointestinal nutrition therapy was found to enhance the production of short-chain fatty acids and preserve intestinal permeability, leading to improved gastrointestinal microbial digestion and barrier defense in elderly patients with diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Abu Dayyeh BK, Maselli DB et al (2021) Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet 398:1965–1973

    Article  PubMed  Google Scholar 

  2. Amin A, Frampton J (2021) Differential effects of L- and D-phenylalanine on pancreatic and gastrointestinal hormone release in humans: a randomized crossover study. Diabetes Obes Metab 23:147–157

    Article  CAS  PubMed  Google Scholar 

  3. Bargetzi L, Brack C, Herrmann J et al (2021) Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial. Ann Oncol 32:1025–1033

    Article  CAS  PubMed  Google Scholar 

  4. Biruete A, Cross TL, Allen JM et al (2021) Effect of dietary inulin supplementation on the gut microbiota composition and derived metabolites of individuals undergoing hemodialysis: a pilot study. J Renal Nutr 31:512–522

    Article  CAS  Google Scholar 

  5. Casajoana A, Guerrero-Pérez F, García Ruiz de Gordejuela A et al (2021) Role of Gastrointestinal hormones as a predictive factor for long-term diabetes remission: randomized trial comparing metabolic gastric bypass, sleeve gastrectomy, and greater curvature plication. Obesity Surg 31:1733–1744

  6. Chen X, Xu Y, Zhang J et al (2021) Exenatide twice daily plus glargine versus aspart 70/30 twice daily in patients with type 2 diabetes with inadequate glycemic control on premixed human insulin and metformin. Endocr Pract 27:790–797

    Article  PubMed  Google Scholar 

  7. Delannoy-Bruno O, Desai C (2021) Evaluating microbiome-directed fibre snacks in gnotobiotic mice and humans. Nature 595:91–95

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dicks L, Jakobs L, Sari M et al (2022) Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial. Eur J Nutr 61:687–701

    Article  CAS  PubMed  Google Scholar 

  9. Ewers B, Vilsbøll T, Andersen HU et al (2019) The dietary education trial in carbohydrate counting (DIET-CARB Study): study protocol for a randomised, parallel, open-label, intervention study comparing different approaches to dietary self-management in patients with type 1 diabetes. BMJ Open 9:e029859

    Article  PubMed  PubMed Central  Google Scholar 

  10. Farsijani S, Cauley JA, Peddada SD et al (2023) Relation between dietary protein intake and gut microbiome composition in community-dwelling older men: findings from the osteoporotic fractures in men study (MrOS). J Nutr 152:2877-2887

  11. Fleseriu M, Dreval A, Bondar I et al (2022) Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 10:102–111

    Article  CAS  PubMed  Google Scholar 

  12. Ai D, Ding N, Wu H (2023) The impact of sarcopenia on nutritional status in elderly patients with gastrointestinal tumors. Sci Rep 13:10308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Frias JP, Lee ML, Carter MM et al (2023) A microbiome-targeting fibre-enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: a double-blind, randomized, placebo-controlled trial. Diabetes Obes Metab 25:1203–1212

    Article  CAS  PubMed  Google Scholar 

  14. Gao J, Guo X, Wei W et al (2021) The association of fried meat consumption with the gut microbiota and fecal metabolites and its impact on glucose homoeostasis. Intestinal Endotoxin Levels Syst Inflammation 44:1970–1979

    CAS  Google Scholar 

  15. Garvey WT, Batterham RL (2022) Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med 28:2083–2091

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Homayouni A, Bagheri N, Mohammad-Alizadeh-Charandabi S et al (2020) Prevention of gestational diabetes mellitus (GDM) and probiotics: mechanism of action: a review. Curr Diabetes Rev 16:538–545

    PubMed  Google Scholar 

  17. Hosomi R, Nishimoto A, Kobayashi T (2020) Dietary Alaska pollock protein alters insulin sensitivity and gut microbiota composition in rats. J Food Sci 85:3628–3637

    Article  CAS  PubMed  Google Scholar 

  18. Kahleova H, Tintera J, Thieme L et al (2021) A plant-based meal affects thalamus perfusion differently than an energy- and macronutrient-matched conventional meal in men with type 2 diabetes, overweight/obese, and healthy men: a three-group randomized crossover study. Clin Nutr 40:1822–1833

    Article  CAS  Google Scholar 

  19. Katada C, Fukazawa S, Sugawara M et al (2021) Randomized study of prevention of gastrointestinal toxicities by nutritional support using an amino acid-rich elemental diet during chemotherapy in patients with esophageal cancer (KDOG 1101). Esophagus 18:296–305

    Article  PubMed  Google Scholar 

  20. Wu H, Li A, Zheng Q et al (2023) LncRNA LZTS1-AS1 induces proliferation, metastasis and inhibits autophagy of pancreatic cancer cells through the miR-532 /TWIST1 signaling pathway. Cancer Cell Int 23:130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Leyrolle Q, Cserjesi R, M DGHM, Zamariola G, et al (2021) Prebiotic effect on mood in obese patients is determined by the initial gut microbiota composition: a randomized, controlled trial. Brain Behavior Immunity 94:289–298.

  22. Lin S, Li C, Shen J et al (2022) Loop versus Roux-en-Y duodenojejunal bypass with sleeve gastrectomy for type 2 diabetes: short-term outcomes of a single-center randomized controlled trial. Surg Obe Related Dis 18:1277–1285

    Article  Google Scholar 

  23. Meessen ECE, Bakker GJ, Nieuwdorp M et al (2021) Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy men. Clin Nutr 40:1013–1021

    Article  CAS  Google Scholar 

  24. Mohamed Elfadil O, Linch FB et al (2022) Safety and effectiveness of radiologic and endoscopic percutaneous gastrostomy placement: a randomized study. J Parenter Enteral Nutr 46:1808–1817

  25. Mokkala K, Paulin N (2021) Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial. Gut 70:309–318

    CAS  PubMed  Google Scholar 

  26. Newsome PN, Buchholtz K, Cusi K et al (2021) A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med 384:1113–1124

    Article  CAS  PubMed  Google Scholar 

  27. Neyrinck AM, Rodriguez J (2021) Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial. Eur J Nutr 60:3159–3170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, The First Hospital of Jilin University, Changchun, 130061, China

    Hefeng Jin

  2. Research Center, Shanghai Healing Medical Information Consulting Co., LTD, No.258 Pingyang Road, Minhang District, Shanghai, 201102, China

    Hui Wu

  3. Data Analysis Center, Shanghai Healink Medical Information Consulting Co., LTD, Beijing, China

    Jianfo Mu

Authors
  1. Jianfo Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hefeng Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hui Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hui Wu.

Ethics declarations

Conflict of interest

The authors declare there is no conflict of interest.

Ethical approval

The research scheme conforms to the principles of Helsinki Declaration and was approved by the Ethics Committee of The First Hospital of Jilin University (No.200034).

Informed consent

All participants provided informed consent before being included in the study.

Human/animal rights

The study was performed in accordance with the Helsinki II declaration.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mu, J., Jin, H. & Wu, H. Effects of nutritional therapy on gastrointestinal microbial digestion and barrier defense markers in elderly patients with diabetes. Aging Clin Exp Res 35, 2667–2674 (2023). https://doi.org/10.1007/s40520-023-02518-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-023-02518-4

Keywords

Search

Navigation